Literature DB >> 15554160

Successful utilization of lyophilized lipoprotein(a) as a biological reagent.

Angelo M Scanu1, Janet Hinman, Ditta Pfaffinger, Celina Edelstein.   

Abstract

Lipoprotein(a) [Lp(a)] represents a class of lipoprotein particles having as a protein moiety apoB-100 linked by a single disulfide bond to apolipoprotein(a) [apo(a)], a multikringle structure with a high degree of homology with plasminogen. A recognized feature of Lp(a) is its instability on storage caused by attendant protein and lipid modifications that affect the structural, functional, and immunological properties of this lipoprotein. Here we present data showing that, under appropriate conditions of cryopreservation, Lp(a) retains the properties of the freshly isolated product, and we provide examples supporting the stability of this cryopreserved product as a primary standard in immunoassay settings and in cell culture systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15554160     DOI: 10.1007/s11745-004-1268-5

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  12 in total

1.  Enzyme-linked immunoassay for Lp[a].

Authors:  G M Fless; M L Snyder; A M Scanu
Journal:  J Lipid Res       Date:  1989-05       Impact factor: 5.922

2.  Properties of human free apolipoprotein(a) and lipoprotein(a) after either freezing or lyophilization in the presence and absence of cryopreservatives.

Authors:  C Edelstein; J Hinman; S Marcovina; A M Scanu
Journal:  Anal Biochem       Date:  2001-01-15       Impact factor: 3.365

3.  Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a).

Authors:  S M Marcovina; J J Albers; A M Scanu; H Kennedy; F Giaculli; K Berg; R Couderc; F Dati; N Rifai; I Sakurabayashi; J R Tate; A Steinmetz
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

4.  Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domain.

Authors:  O Klezovitch; C Edelstein; A M Scanu
Journal:  J Biol Chem       Date:  2001-10-08       Impact factor: 5.157

5.  Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a].

Authors:  C Edelstein; J A Italia; O Klezovitch; A M Scanu
Journal:  J Lipid Res       Date:  1996-08       Impact factor: 5.922

6.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.

Authors:  P X Shaw; S Hörkkö; M K Chang; L K Curtiss; W Palinski; G J Silverman; J L Witztum
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 7.  Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications.

Authors:  Angelo M Scanu
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

8.  Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a).

Authors:  Celina Edelstein; Ditta Pfaffinger; Janet Hinman; Elizabeth Miller; Gregory Lipkind; Sotirios Tsimikas; Claes Bergmark; Godfrey S Getz; Joseph L Witztum; Angelo M Scanu
Journal:  J Biol Chem       Date:  2003-10-13       Impact factor: 5.157

9.  Monoclonal vs. heterogeneous anti-H-8 antibodies in the analysis of the anti-phosphorylcholine response in BALB/c mice.

Authors:  J F Kearney; R Barletta; Z S Quan; J Quintáns
Journal:  Eur J Immunol       Date:  1981-11       Impact factor: 5.532

10.  Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a).

Authors:  G M Fless; M E ZumMallen; A M Scanu
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

View more
  1 in total

Review 1.  Lipoprotein (a): a historical appraisal.

Authors:  Karam M Kostner; Gert M Kostner
Journal:  J Lipid Res       Date:  2016-11-07       Impact factor: 5.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.